IntegriChain acquisition of Blue Fin Group expands its commercialization capabilities and strengthens the company’s market access expertise
PANTHERx Rare was recently selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distribution partner for a new FDA-approved medication, Recorlev® (levoketoconazole).
AscellaHealth recently announced a comprehensive suite of Specialty Pharmacy (SP) services, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug (LDD) fulfillment, and custom Patient Support and HUB Services
ENTADFI will be marketed and distributed through Veru’s own telemedicine and telepharmacy services platform as well as through a partnership with GoodRx
Biologics by McKesson, selected as a specialty pharmacy distributor for three specialty drugs recently, is starting the new year with momentum
OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders
Trilogy announced that its ancillary services subsidiary Synchrony Health Services will now include Synchrony Pharmacy, Synchrony Rehabilitation, Synchrony Wellness Pharmacy and Synchrony Lab under its umbrella
Rite Aid is implementing a number of strategies to make up Q3 2021 PBM revenue shortfall, including closing 63 stores and improving PBM margins from its new rebate aggregation agreement with Prime Therapeutics